tm logo
YUMAB
Live/Registered
Section 71 & 15 – ACCEPTED AND ACKNOWLEDGED

on 27 Sep 2024

Last Applicant/ Owned by

Inhoffenstr. 7

Braunschweig

DE

38124

Serial Number

79191669 filed on 25th Apr 2016

Registration Number

5238680 registered on 11th Jul 2017

in the Principal Register

Correspondent Address

Joseph V. Norvell

Joseph V. Norvell Norvell IP, llc

Chicago, IL 60690

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

YUMAB

Scientific research; technological services being antibody engineering and design; industrial analysis and research services in the nature of laboratory research and new product design services relating to the production of monoclonal antibodies [ Monoclonal antibodies for quantitative determination of leukocyte subsets other than for medical purposes; chemicals components being biochemicals for Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific research; technological services being antibody engineering and design; industrial analysis and research services in the nature of laboratory research and new product design services relating to the production of monoclonal antibodies


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Antibodies, antibody fragments and antigens in the nature of pharmaceuticals for the treatment of cancer, haematopoietic diseases, autoimmune diseases, neurodegenerative diseases, metabolic diseases, eye diseases, infections, diseases of heart and circulation, bone diseases, transplantation, sepsis, intoxications, and adverse drug reactions


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


[ Monoclonal antibodies for quantitative determination of leukocyte subsets other than for medical purposes; chemicals components being biochemicals for producing radio-labelled monoclonal antibodies for industrial or scientific purposes; proteins for detecting antibodies other than for medical purposes; ] monoclonal antibodies for industrial use; monoclonal antibody reagents, other than for medical use; antigens and antibodies being biochemicals for diagnostic use not for medical purposes; immunological antibodies, being biochemicals, other than for medical use; tagged antibodies being biochemicals for scientific use; [ monoclonal antibodies for qualitative determination of leukocyte subsets other than for medical purposes; linkage compounds being biochemicals for scientific purposes for coupling of radioactive compounds to antibodies; reagents for use in the development of hybridoma antibodies other than for medical or veterinary purposes; ] biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; proteins for binding antibodies other than for medical purposes; monoclonal antibodies for scientific use; [ linkage compounds being biochemicals for scientific purposes for coupling antibodies to radio nuclides; monoclonal antibodies for research into haematopoietic systems other than for medical purposes; ] reagents for use in development of monoclonal antibodies other than for medical or veterinary purposes; [ components for producing radio-labelled antibody fragments for industrial or scientific purposes being biochemicals; ] tagged antibodies being biochemicals for laboratory use; reagents in kit form for conducting enzyme-linked immunosorbent assays (elisa) other than for medical or veterinary purposes comprised primarily of biochemicals


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79191669

Mark Type

No Service Mark

Attorney Docket Number

No 13645-3

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
04th Dec 2024PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
27th Sep 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
27th Sep 2024REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
17th Sep 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03rd Apr 2024POST REGISTRATION ACTION MAILED - SEC. 71 & 15
25th Mar 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10th Jul 2023TEAS SECTION 71 & 15 RECEIVED
18th Feb 2023NEW REPRESENTATIVE AT IB RECEIVED
15th Aug 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
10th Nov 2017FINAL DECISION TRANSACTION PROCESSED BY IB